Paper36929005
NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation.
Cheng Y and 11 others. Protein Cell, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. Papers, record 36929005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36929005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Exosomes | Major topic |
| Lung Neoplasms | Major topic |
| Transcriptional Coactivator with PDZ-Binding Motif Proteins | Major topic |
| Humans | |
| Carrier Proteins | |
| Cell Line | |
| Cell Proliferation | |
| Membrane Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21ZR1433100 | Science and Technology Commission of Shanghai Municipality | PubMed | ||
| KF2122 | State Key Laboratory of Oncogenes | PubMed | ||
| 81773115 | National Natural Science Foundation of China | PubMed |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30979708 | An alternatively transcribed TAZ variant negatively regulates JAK-STAT signaling. | EMBO Rep | 2019 | https://conductscience.org/library/papers/30979708 | PubMed |
| 2 | 15688069 | Proteolysis: from the lysosome to ubiquitin and the proteasome. | Nat Rev Mol Cell Biol | 2005 | https://conductscience.org/library/papers/15688069 | PubMed |
| 3 | 23012657 | The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. | Sci Signal | 2012 | https://conductscience.org/library/papers/23012657 | PubMed |
| 4 | 27088444 | Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. | Nat Commun | 2016 | https://conductscience.org/library/papers/27088444 | PubMed |
| 5 | 27300434 | YAP/TAZ at the Roots of Cancer. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27300434 | PubMed |
| 6 | 32354626 | Nicotine promotes tumor progression and epithelial-mesenchymal transition by regulating the miR-155-5p/NDFIP1 axis in pancreatic ductal adenocarcinoma. | Pancreatology | 2020 | https://conductscience.org/library/papers/32354626 | PubMed |
| 7 | 30021156 | The Ubiquitin Ligase Adaptor NDFIP1 Selectively Enforces a CD8+ T Cell Tolerance Checkpoint to High-Dose Antigen. | Cell Rep | 2018 | https://conductscience.org/library/papers/30021156 | PubMed |
| 8 | 29734788 | YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29734788 | PubMed |
| 9 | 19966785 | Rab27a and Rab27b control different steps of the exosome secretion pathway. | Nat Cell Biol | 2010 | https://conductscience.org/library/papers/19966785 | PubMed |
| 10 | 16099986 | TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. | Science | 2005 | https://conductscience.org/library/papers/16099986 | PubMed |
| 11 | 19706893 | Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19706893 | PubMed |
| 12 | 12529404 | Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12529404 | PubMed |
| 13 | 31501420 | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31501420 | PubMed |
| 14 | 30570758 | YAPping about and not forgetting TAZ. | FEBS Lett | 2019 | https://conductscience.org/library/papers/30570758 | PubMed |
| 15 | 26479035 | Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. | Nature | 2015 | https://conductscience.org/library/papers/26479035 | PubMed |
| 16 | 31218102 | The miR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT/mTOR-mediated Warburg effect. | Am J Cancer Res | 2019 | https://conductscience.org/library/papers/31218102 | PubMed |
| 17 | 18309083 | Ceramide triggers budding of exosome vesicles into multivesicular endosomes. | Science | 2008 | https://conductscience.org/library/papers/18309083 | PubMed |
| 18 | 18568018 | TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. | Nat Cell Biol | 2008 | https://conductscience.org/library/papers/18568018 | PubMed |
| 19 | 29970890 | Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29970890 | PubMed |
| 20 | 32764968 | Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32764968 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41992216 | Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in HNSC. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41992216 | PubMed |
| 41827859 | Exosome Engineering for Blocking Gut Dysbiosis and Inducing Cell Death Mechanisms in Glioblastoma Multiforme. | Cells | 2026 | https://conductscience.org/library/papers/41827859 | PubMed |
| 41488061 | Bullous pemphigoid induced by anti-IL-23 monoclonal antibody in a psoriatic patient: a case report. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41488061 | PubMed |
| 40134377 | Progress of research on engineered extracellular vesicles from different sources for disease treatment. | Histol Histopathol | 2025 | https://conductscience.org/library/papers/40134377 | PubMed |
| 40034544 | Exploring the roles and clinical potential of exosome-derived non-coding RNAs in glioma. | IBRO Neurosci Rep | 2025 | https://conductscience.org/library/papers/40034544 | PubMed |
| 39604129 | Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/39604129 | PubMed |
| 38617976 | Enigmatic exosomal connection in lung cancer drug resistance. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38617976 | PubMed |
| 38225729 | Tensile Stress-Activated and Exosome-Transferred YAP/TAZ-Notch Circuit Specifies Type H Endothelial Cell for Segmental Bone Regeneration. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38225729 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36929005
GET https://conductscience.org/api/papers/v1/36929005/references?page=2